首页> 外国专利> METHODS OF SCREENING COMPOUNDS TO PREDICT TOXICITY AND RESIDUAL PROLIFERATIVE AND DIFFERENTIATION CAPACITY OF THE LYMPHO-HEMATOPOIETIC SYSTEM

METHODS OF SCREENING COMPOUNDS TO PREDICT TOXICITY AND RESIDUAL PROLIFERATIVE AND DIFFERENTIATION CAPACITY OF THE LYMPHO-HEMATOPOIETIC SYSTEM

机译:筛选化合物以预测淋巴-造血系统的毒性和残留的增殖和分化能力的方法

摘要

The present invention relates generally to kits that provide reagent mixes and instructions for the use thereof, in performing high-throughput assay methods that provide a method of screening compounds for cytotoxicity or other effects on target cell populations of the lymphohematopoietic system, including specific lineages. The methods measure the luminescent output derived from the intracellular ATP content of incubated target cells, and correlate the luminescence with the proliferative status of the cells. The methods may be used to predict the effect of virtually any compound on the lymphohematopoietic system and may be performed on multiple species simultaneously, thereby providing valuable information regarding potential cytotoxicity prior to preclinical studies and especially, patient clinical trials. The methods also provide the ability to screen compounds early in the drug development profile.
机译:本发明一般涉及在执行高通量测定方法中提供试剂混合物及其使用说明的试剂盒,该方法提供了筛选化合物对淋巴造血系统的靶细胞群(包括特定谱系)的细胞毒性或其他作用的方法。该方法测量源自培养的靶细胞的细胞内ATP含量的发光输出,并将发光与细胞的增殖状态相关。该方法可用于预测几乎任何化合物对淋巴造血系统的影响,并可同时在多个物种上进行,从而在临床前研究尤其是患者临床试验之前提供有关潜在细胞毒性的有价值的信息。该方法还提供了在药物开发过程中早期筛选化合物的能力。

著录项

  • 公开/公告号WO2006089048A3

    专利类型

  • 公开/公告日2007-06-14

    原文格式PDF

  • 申请/专利权人 HEMOGENIX INC.;RICH IVAN N.;

    申请/专利号WO2006US05514

  • 发明设计人 RICH IVAN N.;

    申请日2006-02-16

  • 分类号G01N33/48;C12N5/00;

  • 国家 WO

  • 入库时间 2022-08-21 20:52:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号